AstraZeneca Q4 earnings rise three times on cancer drug sales

The Anglo-Swedish drugmaker worked with Oxford to develop one of the first COVID-19 vaccines authorised for widespread use. AstraZeneca said it hopes to cut the time needed to produce large amounts of any new vaccine to between six and nine months

Related Keywords

Sweden ,United Kingdom ,British , ,Astrazeneca ,University Of Oxford ,Astrazeneca Q4 ,Astrazeneca Q4 Earnings ,Astrazeneca Cancer Drug Sales ,Astrazeneca Cancer Drug Sales Q4 ,Astrazeneca Covid 19 Vaccines ,Astrazeneca Coronavirus Vaccine ,Astrazeneca Medicines ,Astrazeneca Cancer Medicines ,ஸ்வீடந் ,ஒன்றுபட்டது கிஂக்டம் ,பிரிட்டிஷ் ,பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் ,